EP1906916
Augnsviflausn sem samanstendur af augnlyfi, fjöloxamíni og glýkól teygjuspennustillandi miðli, notkun á nefndri samsetningu til framleiðslunnar á lyfi til að meðhöndla augntruflanir.
Status:
EP Einkaleyfi fallið úr gildiEP appl. date:
8.5.2006EP published:
29.10.2008EP application number:
06759259.2
EP translation filed:
10.12.2008Grant published:
15.1.2009EPO information:
European Patent Register
Max expiry date:
7.5.2026Expiry date:
7.5.2013
Title:
OPHTHALMIC SUSPENSION COMPRISING AN OPHTHALMIC DRUG, A POLOXAMINE AND A GLYCOL TONICITY-ADJUSTING AGENT, USE OF SAID COMPOSITION FOR THE MANUFACTURE OF A MEDICAMENT FOR TREATING OPHTHALMIC DISORDERS
Timeline
Today
8.5.2006EP application
29.10.2008EP Publication
10.12.2008Translation submitted
15.1.2009Registration published
7.5.2013Expires
Owner
Name:
ALCON INC.Address:
Bosch 69 P.O.Box 62, CH-6331, Hunenberg, CH
Inventor
Name:
OWEN, Geoffrey, RobertAddress:
Southlake, TX 76092-2871, US
Name:
BROOKS, Amy, C.Address:
Burleson, TX 76028, US
Name:
GRAFF, GustavAddress:
Cleburne, TX 76031, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
679510 PDate:
10.5.2005Country:
US
Annual fees
Number
Paid
Expires
Payer
Number: 4
Paid: 29.4.2009
Expires: 31.5.2010
Payer:
Number: 5
Paid: 20.4.2010
Expires: 31.5.2011
Payer: Sigurjónsson & Thor ehf.
Number: 6
Paid: 19.4.2011
Expires: 7.5.2012
Payer: Sigurjónsson & Thor ehf.
Number: 7
Paid: 20.4.2012
Expires: 7.5.2013
Payer: Sigurjónsson & Thor ehf.